Endovascular Robotic Systems Market Size, Share & Industry Analysis, By Product Type (Electromechanical Manipulation Systems, Magnetic Navigation Systems, and Others), By Component (Imaging Integration System, Robotic Catheters/Guide Sheaths, Interventional Console, and Others), By Application (Embolization & Interventional Oncology, Percutaneous Coronary Intervention (PCI), Peripheral Vascular Intervention (PVI), and Others), By End User (Hospitals, Specialty Clinics, and Others), and Regional Forecast, 2026-2034

The global endovascular robotic systems market size was valued at USD 1.36 billion in 2025 and is projected to grow from USD 1.62 billion in 2026 to USD 4.04 billion by 2034, exhibiting a CAGR of 12.1% during the forecast period. North America dominated the endovascular robotic systems market with a market share of 36.76% in 2025.

Endovascular robotic systems are computer-assisted, remotely operated technology that is used in minimally invasive vascular procedures to enhance stability, precision, and reduce radiation exposure among the patient population. The increasing prevalence of cardiovascular conditions, growing surgical procedure volumes, and integration of hybrid operating rooms are resulting in a rising adoption rate of these systems in the market. The growing aging population is further increasing the prevalence of disorders, resulting in an increase in minimally invasive surgical procedures among patients, thereby fueling the adoption rate of endovascular robotic systems in the market.

• For instance, according to the 2024 statistics published by the Centers for Disease Control & Prevention (CDC), approximately 1 in 20 adults aged 20 and older has coronary artery disease in the U.S.

Additionally, the growing technological advancements in these systems among the prominent players, such as Siemens Healthineers AG and Microbot Medical Inc., among others, are further contributing to the demand for these devices in the market.

Download Free sample to learn more about this report.

Endovascular Robotic Systems Market Trends

Rising Technological Advancements in these Products to Fuel the Market Development

A prominent trend is the shift from first-generation robotic assistance to next-generation systems developed for smooth deployment, smaller footprints, and improved patient outcomes. Additionally, manufacturers are focusing on ecosystem strategic initiatives, including integration of robotics with imaging, navigation, and potentially dedicated systems.

Additionally, growing partnerships among imaging devices companies with players dedicated to robotics systems are further expanding indications of these products, thereby fueling the adoption rate for these products in the market. 

• In September 2025, Siemens Healthineers AG collaborated with Stryker to develop a unique robotic system capable of performing a comprehensive range of elective and emergency neurovascular procedures, including treatment for strokes and aneurysms.

Market Dynamics

Market Drivers

Download Free sample to learn more about this report.

Growing Volume of Invasive Surgical Procedures to Fuel the Market Growth

The growing prevalence of chronic conditions such as cardiovascular disorders and others is resulting in an increasing number of minimally invasive surgical procedures among the patient population, subsequently boosting the demand for endovascular robotic systems in the market.

• For instance, according to 2023 data published by the American College of Cardiology Foundation (ACCF), it was reported that about 240 million people are affected by Ischemic heart disease in the U.S.

This, along with increasing focus of health facilities on scaling complex interventions, further increases the adoption rate for robotics systems supporting higher throughput and reproducibility. Therefore, the factors above, along with the rising focus of prominent players on introducing R&D activities to launch novel devices, are anticipated to fuel the adoption rate of these systems, thereby supporting the global endovascular robotic systems market size.

Market Restraints

High Cost Associated with Advanced Devices to Hamper the Market Growth

There is a growing adoption of robotic systems for minimally invasive surgical procedures among the patient population. However, the high cost associated with advanced robotic systems hampers the adoption rate for these products, particularly in developing countries, including Brazil, Mexico, and others.

Moreover, the hospitals may justify these investments through higher procedure volumes; however, many mid-tier centers face challenges owing to the high cost of robotics systems. The additional cost, including the cost associated with staff training, installation/integration, annual service coverage, and procedure-linked consumables, further increases the financial burden, thereby limiting the growth of the market globally.

• For instance, in April 2020, a U.S. federal purchase order for full-service maintenance of the Corindus/CorPath GRX system listed a ceiling value of USD 247.5k over an expected 5-year duration, highlighting the scale of ongoing service exposure.

Market Opportunities

Growing Expansion of Healthcare Networks in Emerging Nations to Create Market Opportunities

There is a growing expansion of healthcare networks in emerging nations, including India, Mexico, and others. The increasing number of surgeries, expansion of hospital infrastructure, growing number of hospitals, and catheterization laboratories are subsequently boosting the adoption of endovascular robotic systems in clinical settings.

Additionally, the increasing preference for minimally invasive surgical procedures due to their benefits, such as shorter patient stays, faster turnover times, and others, is fueling the focus of healthcare settings towards adopting next-generation robotic systems in healthcare facilities.

• According to 2021 data published by Medical Buyer, there are about 1,600 catheterization laboratories in India.

Market Challenges

Limited Healthcare Access in Developing Nations to Stifle the Market Growth

There is a growing demand for minimally invasive surgeries among the patient population. However, shortage of technologically advanced products, limited healthcare expenditure, coupled with an inadequate reimbursement framework, especially in emerging nations, are resulting in limited access to healthcare facilities among the patient population.

Furthermore, a limited number of clinical facilities and limited professionals, among others, are some of the prominent factors, resulting in the delayed minimally invasive surgical procedures among the patient population, particularly in emerging countries, including Mexico, Brazil, among others.

• For instance, according to 2023 data published by The World Bank Group (WBG), approximately 4.5 billion people lack full access to essential health services worldwide.

SEGMENTATION ANALYSIS

By Product Type

Increasing Number of Surgical Procedures Led to the Dominance of the Electromechanical Manipulation Systems

Based on the product type, the market is classified into electromechanical manipulation systems, magnetic navigation systems, and others.

To know how our report can help streamline your business, Speak to Analyst

The electromechanical manipulation systems segment held the largest revenue share in 2025. The growth is owing to the growing prevalence of chronic conditions among patients, resulting in a rising number of minimally invasive surgical procedures globally. This, along with the increasing focus of prominent companies on launching innovative products, is further anticipated to contribute to the global endovascular robotic systems market growth.

• For instance, according to 2024 data published by Science Direct, more than 1 million cardiac surgical procedures are estimated to occur yearly globally.

The magnetic navigation systems segment is expected to grow at a CAGR of 12.2% over the forecast period.

By Component

Increasing Benefits of Interventional Console Led to the Dominance of the Segment

Based on component, the market is segmented into imaging integration system, robotic catheters/ guide sheaths, interventional console, and others.

The interventional console segment dominated the global market share by 38.3% in 2025. The growth is owing to the growing benefits of interventional consoles, such as enhance procedural accuracy, improved stability in catheter manipulation, reduced radiation exposure, improved clinical outcomes, and others, resulting in a growing demand for these interventional consoles, thereby supporting the penetration rate of these products in the market.

• For instance, in April 2022, Siemens Healthineers AG announced results for its radiation-shielded interventional workstation/console used to remotely control guide catheter/guidewire/rapid-exchange catheter movements, with about 95.2% physician radiation reduction when using the CorPath robotic system.

The robotic catheters/ guide sheaths segment is set to flourish with a CAGR of 13.0% over the forecast period.

By Application

Increasing Prevalence of Chronic Conditions Led to the Dominance of the Percutaneous Coronary Intervention (PCI) Segment

Based on application, the market is segmented into embolization & interventional oncology, percutaneous coronary intervention (PCI), peripheral vascular intervention (PVI), and others.

The percutaneous coronary intervention (PCI) segment dominated the global market share of 45.6% in 2025. The growth is owing to the increasing prevalence of chronic conditions, such as cardiovascular diseases, among others, resulting in a growing number of these procedures globally, thereby supporting the adoption rate of these devices in the market.

• For instance, according to the 2021 data published by the American Heart Association, Inc., (AHA), over 600,000 percutaneous coronary intervention (PCI) procedures are performed in the U.S. each year.

The embolization & interventional oncology segment is set to flourish with a growth rate of 17.7% across the forecast period.

By End-user

Rising Number of Surgical Procedures Led to the Hospitals Segmental Dominance

Based on end user, the market is classified into hospitals, specialty clinics, and others.

The hospitals segment dominated the market in 2025. The growing prevalence of chronic diseases, increasing number of surgical procedures, and rising number of hospitals, among others, are some of the prominent factors supporting the growth of the segment. Furthermore, the segment is set to hold a 77.3% share in 2026.

• For instance, according to 2025 data published by Statistisches Bundesamt, there are approximately 1,874 hospitals in Germany.

In addition, the specialty clinics’ segment is projected to grow at a 13.1% CAGR during the forecast period.

Endovascular Robotic Systems Market Regional Outlook

Based on region, the market has been studied across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

North America

To get more information on the regional analysis of this market, Download Free sample

The North America market held the dominant share in 2024, valued at USD 0.41 billion, and also led the market share in 2025 with USD 0.50 billion. The rising prevalence of chronic diseases, a high number of minimally invasive surgeries, advanced hospital infrastructure, favorable reimbursement policies, and a growing number of procedures such as peripheral vascular interventions, among others, are some of the vital factors contributing to the growth of the segment in the market.

• For instance, according to 2018 statistics published by Science Direct, there are about 2,000 cardiac catheterization laboratories in the U.S.

U.S. Endovascular Robotic Systems Market

Based on North America’s strong contribution and the U.S. dominance within the region, the U.S. market is expected to hit USD 0.53 billion in 2026, accounting for roughly 32.4% of global sales.

Europe

Europe is projected to record a growth rate of 10.9% during the forecast period, which is the second highest among all regions, and to reach a valuation of USD 0.47 billion by 2026. The growing number of minimally invasive procedures and advanced medical technologies in these products is likely to support the market growth.

U.K Endovascular Robotic Systems Market

The U.K. market in 2026 is to be estimated at USD 0.47 billion, representing roughly 4.0% of global revenues.

Germany Endovascular Robotic Systems Market

Germany’s market is projected to reach approximately USD 0.10 billion in 2026, equivalent to around 5.9% of global sales.

Asia Pacific

Asia Pacific is estimated to reach USD 0.41 billion in 2026 and secure the position of the third-largest region in the market. The prevalence of coronary artery disease, the fastest growth in surgical procedures volume, expanding hospital infrastructure, and rising healthcare access are anticipated to support the development of the market. In the region, India and China are both estimated to reach USD 0.05 billion and USD 0.13 billion, respectively, in 2026.

Japan Endovascular Robotic Systems Market

The Japan market in 2026 is estimated to hit USD 0.09 billion, accounting for roughly 5.4% of global revenues. Japan has historically reported a relatively increasing prevalence of chronic diseases, with a growing number of surgical procedure volumes.

China Endovascular Robotic Systems Market

China’s market is projected to be one of the largest globally, with 2026 revenues estimated at around USD 0.13 billion, representing roughly 8.3% of global sales.

India Endovascular Robotic Systems Market

The Indian market size in 2026 is estimated at around USD 0.05 billion, accounting for roughly 3.3% of global revenues.

Latin America and Middle East & Africa

The Latin America and Middle East & Africa regions are expected to witness moderate growth in the market during the forecast period. The Latin America market is set to reach a valuation of USD 0.09 billion in 2026.  The growth is due to the increasing number of surgical procedures in these regions. In the Middle East & Africa, the GCC is set to reach a value of USD 0.03 billion in 2026.

South Africa Endovascular Robotic Systems Market

The South African market is projected to reach around USD 0.03 billion in 2026, representing roughly 0.7% of global revenues.

Competitive Landscape

Key Industry Players

Robust and Diversified Product Portfolio Contributes to the Dominance of the Industry Players

A robust and diversified product portfolio, along with a significant emphasis on inorganic growth strategies globally, is one of the vital factors contributing to the dominance of these companies in the market. Siemens Healthineers AG, and Microbot Medical Inc., are major companies in the market in 2025. Moreover, the growing focus of key players on attending conferences and strategic partnerships is expected to strengthen their presence, further supporting the global endovascular robotic systems market share.

• For instance, in February 2026, Microbot Medical Inc., a developer and distributor of the innovative LIBERTY Endovascular Robotic System, attended the Society of Interventional Oncology (SIO) annual meeting, being held in Savannah, February 2026.

Other key players, including Robocath, Inc., and others, are also growing in the market, primarily due to their increasing focus on presenting their clinical studies results, and mergers and acquisitions are expected to strengthen their presence in the market.

List of Key Endovascular Robotic Systems Companies Profiled

• Siemens Healthineers AG (Germany)
• Microbot Medical, Inc. (U.S.)
• Stereotaxis, Inc. (U.S.)
• Sentante (Lithuania)
• Nanoflex Robotics AG (Switzerland)
• Remedy Robotics, Inc. (U.S.)
• Robocath, Inc. (France)
• XCath (U.S.)

KEY INDUSTRY DEVELOPMENTS

• November 2025: XCath has announced the successful first-in-human use of its endovascular robotic system to treat three patients with complex brain aneurysms. This helped the company to increase its brand presence.
• April 2025: Microbot Medical Inc. shares results from its pivotal clinical trial, achieving 100% robotic navigation success for the LIBERTY Endovascular Robotic System.
• January 2025: Microbot Medical Inc., received an FDA submission for the commercialization of the LIBERTY endovascular robotic system. This helped the company to increase its brand presence.
• December 2023: Shanghai MicroPort MedBot (Group) Co., Ltd. and Robocath, Inc., a French company, collaborated and formed a joint venture known as CathBot (Shanghai) Robotics Co., Ltd. Their R-ONE vascular intervention surgical robot has officially obtained market approval from the National Medical Products Administration (NMPA).
• October 2023: Robocath, Inc., a company that designs, develops, and commercializes innovative robotic solutions for the treatment of cardiovascular diseases, announced the results of its ‘CARE’ clinical trial focusing on robotic carotid stenting. This study was launched in July 2021 by the company and Rennes University Hospital in France.
• May 2022: Robocath, Inc., a company that designs, develops, and commercializes innovative robotic platforms for the treatment of vascular diseases, presents the results of its R-Evolution clinical study at the international EuroPCR conference.
• May 2022: Cathbot (Shanghai) Robot Co., Ltd., announced that all surgeries under the registration clinical trial for the R-ONE Vascular Interventional Surgical Robot have been completed, making it the first vascular interventional robotic system to complete a large-scale clinical trial in China.

REPORT COVERAGE

The report provides a detailed global endovascular robotic systems market analysis and focuses on key aspects such as leading companies and market segmentation, including product type, component, application, and end user. Besides this, the global report offers insights into the market growth trends and highlights key industry developments. In addition to the aforementioned factors, the report encompasses several factors that have contributed to the growth and advancement of the market over recent years.

Request for Customization   to gain extensive market insights.

Report Scope & Segmentation